About Abryl Formulations Private Limited
Data last updated: 11 March 2026
Abryl Formulations Private Limited is a foreign private limited company based in Bathinda, Punjab, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 August 2006, the company has been in operation for over 20 years.
Registered with ROC Chandigarh under CIN U24239PB2006FTC030567.
Capital: an authorised share capital of ₹9 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors Aditya Singla and Sanjeev Agnihotri.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 17406A Street No. 3 Minocha Colony, Bathinda, Punjab, India – 151001.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.19 Lakh, a growth of 55% compared to the previous year.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abryl.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address17406A Street No. 3 Minocha Colony, Bathinda, Punjab, India – 151001
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Abryl Formulations Private Limited
Abryl Formulations Private Limited has one previous CIN (Corporate Identification Number): L24239PB2006FTC030567. The current CIN is U24239PB2006FTC030567, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239PB2006FTC030567 | Current |
| L24239PB2006FTC030567 | Previous |
Business Activity of Abryl Formulations Private Limited
Abryl Formulations Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details for Abryl Formulations Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Abryl Formulations Private Limited
Abryl Formulations Private Limited is audited by PRIYA BHUSHAN SHARMA & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRIYA BHUSHAN SHARMA & CO. | Locked | Locked | Locked |
Complete auditor history for Abryl Formulations Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Abryl Formulations Private Limited
Abryl Formulations Private Limited is currently managed by 2 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Aditya Singla
Also directs:
Abryl Formulations Private Limited
|
Director | 20 Aug 2024 | 1 Years 10 Months | Current |
|
Sanjeev Agnihotri
Also directs:
Abryl Formulations Private Limited
|
Director | 11 Oct 2025 | 0 Years 9 Months | Current |
Financials of Abryl Formulations Private Limited FY 2025 filings available
Abryl Formulations Private Limited reported revenue of ₹87.19 Lakh (up 55.00% YoY) for FY 2025.
Ten-year financial statements for Abryl Formulations Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Abryl Formulations Private Limited
Shareholding and ownership data for Abryl Formulations Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Abryl Formulations Private Limited
Abryl Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Abryl Formulations Private Limited
View historical data on people associated with Abryl Formulations Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Abryl Formulations Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Abryl Formulations Private Limited
GST registrations and filing compliance for Abryl Formulations Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Abryl Formulations Private Limited
Credit ratings, litigation, and regulatory alerts for Abryl Formulations Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Abryl Formulations Private Limited
MSME payment history for Abryl Formulations Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abryl Formulations Private Limited
Corporate group structure for Abryl Formulations Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abryl Formulations Private Limited
MCA filings and documents for Abryl Formulations Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Abryl Formulations Private Limited
Frequently Asked Questions about Abryl Formulations Private Limited
Abryl Formulations Private Limited is an active foreign private limited company in the pharma sector based in Bathinda, Punjab, India. It was incorporated on 23 August 2006 (20+ years old) and is registered under CIN U24239PB2006FTC030567.
Abryl Formulations Private Limited reported revenue of ₹87.19 Lakh for FY 2025 (up 55.00% YoY).
The current directors of Abryl Formulations Private Limited are:
- Aditya Singla - Director
- Sanjeev Agnihotri - Director
The primary industry of Abryl Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Abryl Formulations Private Limited can be reached at the registered office: 17406A Street No. 3 Minocha Colony, Bathinda, Punjab, India – 151001, or through the website abryl.in.
The authorised capital is ₹9 Lakh, and the paid-up capital is ₹9 Lakh.